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SYNOPSIS 
 
Diabetic cardiomyopathy refers to the changes in contractility that occur to the diabetic 
heart that can arise in the absence of vascular disease. Mitochondrial bioenergetic deficits and 
increased free radical production are pathological hallmarks of diabetic cardiomyopathy but the 
mechanisms and causal relationships between mitochondrial deficits and the progression of 
disease are not understood.  We evaluated cardiac mitochondrial function in a rodent model of 
chronic type 1 diabetes (OVE26 mice) prior to onset of contractility deficits. We found that the 
most pronounced change in OVE26 heart mitochondria is severe metabolic inflexibility.  This 
inflexibility is characterized by large deficits in mitochondrial respiration measured in the 
presence of non-fatty acid substrates. Metabolic inflexibility occurred concomitantly with 
decreased activities of pyruvate dehydrogenase and complex II.  Hyper-acetylation of protein 
lysine was also observed.  Treatment of control heart mitochondria with acetic anhydride, an 
acetylating agent, preferentially inhibited respiration by non-fatty acid substrates and increased 
superoxide production.  We have concluded that metabolic inflexibility, induced by discrete 
enzymatic and molecular changes, including hyper-acetylation of protein lysines, precedes 
mitochondrial defects in a chronic rodent model of type 1 diabetes.   
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INTRODUCTION 
 
Diabetic cardiomyopathy is associated with contractility defects that may occur in the 
absence of other risk factors such as coronary artery disease.  Mitochondrial bioenergetic 
deficits and increased free radical production are pathological hallmarks of the diabetic heart [1-
4]. These mitochondrial alterations are thought to promote progression of diabetic 
cardiomyopathy [5-9]. However, the mechanisms underlying mitochondrial dysfunction and 
whether they precede or follow the development of disease is unknown. It is therefore critical to 
define the molecular changes that occur to mitochondria prior to cardiac deficits.   
  
Deficits in mitochondrial function associated with diabetes have been linked to metabolic 
defects [4, 6, 10].  The heart’s constant demand for energy comes primarily from mitochondrial 
oxidative phosphorylation, which accounts for 95% of produced ATP [11].  To support oxidative 
phosphorylation, the heart derives 60-90% of its ATP from oxidation of fatty acids, with the 
remainder coming primarily from pyruvate and lactate [12].  However, under a chronic diabetic 
state the ability of the heart to switch between available oxidizable substrates is impaired and 
under these conditions it relies almost exclusively on fatty acid metabolism [12].  This metabolic 
inflexibility may be expected to confer increased mitochondrial damage.  This is, in part, 
because of the accumulation of potentially toxic incomplete products of fatty acid oxidation.  
Such products increase stress on cardiac mitochondria and increase insulin resistance [13, 14]. 
In addition in vitro studies show that mitochondrial respiration by fatty acid oxidation increases 
free radical production compared to that produced by other carbon sources [15].  This suggests 
that metabolic inflexibility itself may contribute to disrupted mitochondrial function and increased 
free radical production. 
 
The post-translation modification, protein lysine acetylation, has emerged as an 
important metabolic regulatory mechanism in mitochondria. Electron transport chain, Krebs 
cycle enzymes, and fatty acid oxidation enzymes are all targets of this post-translational 
modification [16-18]. However, the functional consequences on individual enzyme activities 
have not been fully resolved. Levels of protein lysine acetylation change between fasting and 
feeding [19, 20]. In general, the change in acetylation and deacetylation of discrete targets 
appears to correspond to a coordinated shift in metabolic fuel selections. In addition, 
mitochondrial protein acetylation may also serve as an important means of regulating 
mitochondrial free radical production and metabolism.  For example, acetylation of SOD2 and 
ICDH2 decreases their activities, thereby decreasing dismutation of superoxide and decreasing 
NADPH available for reducing glutathione, respectively [21, 22]. How protein lysine acetylation 
is affected in the chronic diabetic heart and how this relates to mitochondrial dysfunction and 
increased free radical production remain to be rigorously defined.  We hypothesize that changes 
in protein lysine acetylation contribute to the development of diabetic cardiomyopathy.   
 
 The present study was undertaken to examine mitochondrial function and metabolic 
flexibility in OVE26 transgenic mice, an established model of chronic type 1 diabetes.  Our goal 
was to identify how mitochondrial fuel selection was affected in hearts prior to the onset of 
cardiac contractility deficits, and to determine underlying molecular changes that contribute to 
diabetes-induced pathology.   
 
 
EXPERIMENTAL 
 
Animals: OVE26 and age-matched wild type (FVB) mice were obtained from Jackson 
Laboratories.  Mice were fed standard lab chow ad libitum.  At 2-5 months, mice were 
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euthanized by cervical dislocation.  All animal procedures were in accordance with OMRF 
Institutional Animal Care and Use Committee guidelines. 
 
In vivo MRI:  Cardiac function was measured by MRI as previously described [9]. Data was 
collected on an 11.74T wide-bore Bruker Spectrometer. Methods included with the Intragate 
package (Bruker Biospin) were used for collection of images. Three hundred (300) repetitions of 
a single slice placed axially at the mid-ventricular position were used for collection of images 
which were used to calculate fractional shortening. Black blood images were used for these 
measurements which allowed clear visualization of the left ventricle wall. The images 
representing ¾ of a cardiac period were produced by retrospective means assuming a 
respiratory rate of 60 beats per minute (bpm) and a cardiac rate of 450 bpm using software 
provided by the Intragate method. The field of view (FOV) for these images was 2.56×2.56cm 
and the matrix size was 128×128, producing images with 200 μm in-plane resolution in a total 
acquisition time of 4.2 minutes. For ejection fraction calculations, images were collected with the 
same parameters as described above but without presaturation and in multiple slices since only 
blood volume measurements are important in this case. The slice thickness was 1mm and each 
slice was advanced manually to the next position and varied from 6 to 7 slices depending on the 
size of the heart. 
 
Image analysis was performed with Paravision software (version 5.0). For fractional 
shortening calculations the black blood images were used and wall thickness from the 
reconstructed images were determined at end-diastole (ED) and end-systole (ES). Percent 
fractional shortening was calculated as %FS = ((ED – ES) / ED) × 100. Conventionally (i.e. with 
echocardiograms) %FS is calculated by determining the diameter of the left ventricle wall at ED 
and ES. Raw wall thickness values are also included in Table 1. Percent ejection fraction (%EF) 
was calculated by determining volumes of the left ventricle at end-diastole and end-systole, so 
%EF = ((VD – VS) / VD) × 100, where VD and VS are the respective volumes.  Sets of multi-
slice images were used for calculation of volumes. 
 
Isolation of Cardiac Mitochondria: Male OVE26 or age-matched FVB mice were euthanized by 
cervical dislocation.  Chest cavities were immediately opened and hearts were perfused with 3-5 
mL of ice-cold buffer containing 210 mM mannitol, 70 mM sucrose, 1.0 mM EDTA, 5.0 mM 
MOPS, pH 7.4 (buffer A) via injection into the left ventricle.  Hearts were excised and placed into 
10 mL of buffer A and then minced with scissors.  This was followed by Polytron 
homogenization.  The homogenate was spun at 500 g for 5 min at 4 ºC, the supernatant 
collected and passed through cheesecloth, and spun again for 10 min at 5000 g.   The resulting 
mitochondrial pellet was resuspended in approximately 60 μL of buffer A and protein 
concentration determined by the BCA method (Pierce) using BSA as a standard.  
 
Mitochondrial Respiration:  Mitochondria were diluted to 0.25 mg/mL in 210 mM mannitol, 70 
mM sucrose, 5.0 mM KH2PO4, and 10 mM MOPS, pH 7.4 (buffer B) containing either 10 mM 
glutamate/2.5 mM malate, 0.1 mM pyruvate/1.0 mM malate, 30 μM palmitoylcarnitine/0.1 mM 
malate, or 10 mM succinate.  0.5 mg/mL BSA was added to buffer B for 
palmitoylcarnitine/malate experiments. For chemically induced acetylation of FVB wild type 
heart mitochondria, samples (0.25 mg/mL) were treated with indicated amounts of acetic 
anhydride in buffer B with 0.5 mg/mL BSA for 2.0 min at 20 °C, and the reaction then stopped 
with the addition of 3.0 mM lysine. Respiration was measured polarographically at 25 ºC with a 
Clark-style oxygen electrode (Instech).  State 3 respiration [23] was initiated by addition of ADP 
(0.5 mM). The starting amount of molecular oxygen in the 0.6 mL electrode chamber was based 
on the assumption that 265 nmol of molecular oxygen are dissolved per milliliter at atmospheric 
pressure and 20ºC. 
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Enzyme Activity Assays: PDH activity was measured as follows.  Mitochondria were diluted to 
0.05 mg/mL in 25 mM MOPS pH 7.2 containing 0.025% Triton X-100.  The reduction of 0.5 mM 
NAD+ was then followed spectrophotometrically at 340 nm (ε = 6,200 × M-1 × m-1) upon addition 
of 0.2 mM TPP, 0.04 mM CoASH, and 10 mM pyruvate.  NADH oxidase, an overall assessment 
of electron transport chain activity through complexes I-III-IV was measured as follows. Frozen 
and thawed mitochondria were diluted into 10 mM MOPS at 0.025 mg/mL and the rotenone-
sensitive rate of oxidation of 0.1 mM NADH followed spectrophotometrically at 340 nm.  
Complex II activity was measured as follows.  Mitochondria were diluted to 0.25 mg/mL in buffer 
B with 10 mM succinate for 2.0 min.  This procedure reverses oxaloacetate-mediated inhibition 
and ensures the enzyme is in the fully active state [24]. Samples were diluted 1:10 in a buffer 
containing 25 mM MOPS pH 7.2 and 0.025% Triton X-100. Complex II activity was measured 
spectrophotometrically by the thenoyltrifluoroacetone (TTFA) sensitive reduction of ubiquinone-
1 (50 μM) at 280 nm (ε = 13,700 × M-1 × cm-1) [24].  The presence of 0.025% Triton X-100 
completely blocked NADH oxidation and ubiquinone reduction by complex I [25] and ubiquinol 
oxidation by complex III. The combined malate dehydrogenase (MDH) and 
glutamate/oxaloacetate transaminase activities were measured as follows. Mitochondria (0.025 
mg/mL final) were diluted in 25 mM MOPS pH 7.2 with 0.025% Triton X-100 and 5.0 mM 
malate. The reduction of 1.0 mM NAD+ was then followed at 340 nm.  The forward MDH 
reaction quickly halts with the accumulation of oxaloacetate [24], but was found to rapidly 
proceed with the addition of 10 mM glutamate.  Likewise, in the presence of glutamate and 
NAD+ alone, no production of NADH was detectable. This confirms previous reports of low 
glutamate dehydrogenase activity in the heart and that glutamate entry into Krebs cycle 
proceeds primarily via transamination [26].  The MDH mediated reduction of NAD+ in the 
presence of glutamate and malate was linear for >3.0 min.   
 
SDS-PAGE and Western blot analysis:  Indicated amounts of mitochondrial protein were diluted 
into SDS-PAGE sample buffer containing 25 mM DTT. For chemically induced acetylation of 
FVB wild type heart mitochondria, samples (0.25 mg/mL) were treated with indicated amounts 
of acetic anhydride in buffer B for 2.0 min at 20 °C, and the reaction then stopped with the 
addition of 3.0 mM lysine.  Following SDS-PAGE (4-12% polyacrylamide, NuPAGE Gel, Life 
Sciences), gels were either stained with Gel Code Blue (Life Sciences) according to the 
manufacturer’s protocol,  or proteins were transferred to nitrocellulose and blocked for 1 h at 23 
°C with 0.5% BSA in TPBS.   Blots were then incubated for overnight with a polyclonal primary 
antibody against acetyl lysine (1:000 dilution, Cell Signaling), SDHA (1:100 dilution, Santa Cruz 
Biotechnology), the E2 subunit of α-ketoglutarate dehydrogenase (KGDH)[27], pyruvate 
dehydrogenase (1:000 dilution, Abcam), or phospho-293 PDH E1 subunit (1:000 dilution, 
Abcam). Blots were then washed 5 × 5 min with TTBS and incubated with goat anti-rabbit HRP-
conjugated antibody (1:20,000 dilution, Thermo Scientific) for 1 h. Following 3 × 5 washes with 
TTBS, blots were exposed to Super-Signal West Pico Chemiluminescent Substrate (Thermo 
Scientific) and imaged with an Alpha Innotech Fluorchem HD2 imaging system.  Unless 
indicated, exposure times were chosen so that no band intensities exceeded saturation.  
Densitometry was performed by analysis with ImageJ software (NIH).  Band intensities were 
compared to those of loading controls.   
 
Superoxide Anion Production Measurements:  The NADH-supported rate of O2•– production was 
measured as described previously [28, 29].  Briefly, the oxidation of hydroethidine by O2•– to the 
fluorescent product 2-hydroxyethidium was measured by fluorescence spectroscopy.  The 
fluorescent signals were recorded (excitation, 480 nm; emission, 567 nm) over time utilizing 10 
µM hydroethidine and 500 µM NADH. No change in fluorescence was seen with additional 
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DNA, indicating endogenous nucleotides were sufficient for the formation of 2-hydroxyethidium.  
CuZn-SOD (8.0 U/mL) was used to test the specificity of the measurement for superoxide anion.  
 
Statistical analysis: Data are presented as means ± SD or SE, as indicated.  The data were 
evaluated utilizing a two-tailed t-test.  Indicated statistical significance was assigned for p ≤ 
0.05. 
 
 
RESULTS 
 
Characterization of OVE26 mice:  OVE26 mice are a well-characterized model for 
chronic type 1 diabetes.  These transgenic mice specifically over-express calmodulin in the 
pancreas, impeding the release of insulin [30]. Blood glucose levels of OVE26 mice were 
routinely above 600 mg/dL (not shown). Two to five month old mice were used in all 
experiments. MRI analysis of cardiac contractility is shown in Table 1. Consistent with a 
previous report [31], the ejection fraction and percent fractional shortening displayed an 
increased trend (20.6 and 11.8%, respectively) in OVE26 relative to FVB wild-type but failed to 
reach statistical significance.   No differences were seen in ES and ED left ventricular wall 
thickness between OVE26 and FVB mice.  Collectively, the data suggests subtle changes in 
cardiac function in 2-5 month old OVE26 mice, without indications of overt cardiomyopathy.   
 
 Mitochondrial function:  Mitochondrial yields from OVE26 hearts were greater than from 
FVB (.94 ± .06 and .82 ± .06 mg total protein, n=7, respectively).  This is consistent with a 
reported increase in mitochondrial biogenesis and content in this animal model [8].  It has been 
previously reported that OVE26 heart mitochondria from five-month old animals exhibit declines 
in respiration when using glutamate as an oxidizable substrate [8].  However, the capacity to 
use other carbon-sources to support respiration had not been examined in this model prior to 
our studies. Typical oxygen trace measurements are shown in Fig. 1A and ADP-dependent 
state 3 respiration rates are quantified in Fig. 1B.  As shown in Fig. 1, we observed severe 
deficits (52.1% decrease) in state 3 respiration when utilizing glutamate as substrate.  
Respiration utilizing pyruvate as substrate also showed a severe decline (45.5%).  The amount 
of pyruvate used (0.1 mM) was chosen to minimize the confounding effects of high pyruvate 
concentrations on pyruvate dehydrogenase (PDH) and pyruvate dehydrogenase kinase 
activities. This concentration is also well above the reported Km of pyruvate in the PDH reaction 
(35 µM) [32].  Furthermore, similar declines were seen when 10 mM pyruvate was used (data 
not shown).  Succinate-linked respiration, performed in the absence of rotenone, exhibited a 
24.8% decline in state 3 respiration.  Rotenone was omitted because of our previous finding that 
rotenone masks H2O2-mediated declines in succinate-linked respiration [24].  The deficits 
observed when using pyruvate or glutamate as substrates were to an extent that the transition 
from state 3 to state 4 was not readily discernible (Fig. 1A).  In contrast to other substrates, no 
differences between OVE26 and FVB wild-type respiration profiles were observed when using 
palmitoylcarnitine as substrate.  This result is significant because it suggests the mitochondrial 
deficits demonstrated with other oxidizable substrates are not due to overt damage to 
mitochondrial integrity, electron transport chain activities, ADP/ATP transport, or ATP synthase 
activity.  We conclude that a major change to OVE26 heart mitochondria is a severe metabolic 
inflexibility.   
 
 Mechanisms of mitochondrial respiratory deficiencies:  OVE26 heart mitochondria exhibit 
severe deficiencies utilizing non-fatty acid substrates.  The inefficient utilization of pyruvate may 
be mediated, in part, by a decrease in pyruvate dehydrogenase (PDH) activity [33].    Indeed, as 
shown in Fig. 2A, PDH activity was decreased 51.6% in OVE26 heart mitochondria versus FVB 
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controls.  PDH regulation is multifaceted and includes inhibitory phosphorylation of the E1 
subunit at multiple sites.  Examination of the phosphorylation state of E1 subunits revealed a 
significant increase in OVE26 heart mitochondria as compared to FVB controls (Fig. 2B). The 
ratio of band intensities of phosphorylated to non-phosphorylated E1 was .20 ± .05 and .33 ± 
.06 for FVB and OVE26, respectively (Fig 2B). This result suggests decreased PDH activity via 
hyper-phosphorylation may contribute to the inefficient utilization of pyruvate shown in Fig. 1.    
 
Succinate-linked respiration is distinct from other respiratory substrates in that electrons 
are introduced at complex II instead of complex I.  We therefore hypothesized that a decrease in 
complex II activity may contribute to decreased succinate-supported respiration in OVE26 heart 
mitochondria. As shown in Fig. 3, complex II activity is significantly impaired (28.3% decrease) 
in OVE26 heart mitochondria.  Thus, a decrease in complex II activity may contribute to a 
decreased rate of succinate-supported respiration by decreasing flux through complex II into the 
electron transport chain and by impeding the Krebs cycle.  In contrast, no decrease was 
observed in NADH oxidase activity, which is a combination of activities through complexes I-III-
IV of the electron transport chain (633.5 ± 56.8 versus 662.6 ± 70.3 nmol NADH oxidized × min–1 
× mg-1 for FVB and OVE26, respectively).  This further supports that deficiencies in NADH-
supported respiration, observed with glutamate and pyruvate, are not due to deficiencies in the 
electron transport chain.   
 
 The oxidation of glutamate in heart mitochondria primarily proceeds via the 
transaminase reaction in which glutamate and malate are converted into α-ketoglutarate and 
aspartate [34].   However, measurement of the combined malate dehydrogenase and 
glutamate/malate transaminase activity revealed no differences between OVE26 and FVB 
control heart mitochondria (data not shown).  Thus, the inefficient utilization of glutamate as an 
oxidizable substrate (Fig. 1B) is not likely due to inhibition of this metabolic step. 
  
 OVE26 heart mitochondria exhibit hyper-acetylation of protein lysines:  Recent studies 
have demonstrated that protein lysine acetylation is an important determinant in metabolic 
regulation.  Specifically, protein lysine acetylation levels fluctuate with fed versus fasted state 
and this is likely to reflect changes in fuel selection and nutrients available for energy 
production.  We therefore hypothesized that protein lysine acetylation may be altered in OVE26 
heart mitochondria based on their observed mitochondrial metabolic inflexibility.  Protein lysine 
acetylation measured by Western blot analysis was significantly increased in OVE26 heart 
mitochondria. As shown in Fig. 4A, OVE26 heart mitochondria exhibit an approximate 2.5 fold 
increase in total acetylation levels compared to age-matched FVB controls. However, the total 
protein profiles looked similar between control and diabetic animals (Fig 4B). Comparing the 
mitochondrial fraction with the cytosolic fraction, we found that the majority of hyper-acetylated 
proteins in OVE26 hearts are mitochondrial (Fig. 4B). Separation of isolated mitochondria into 
membrane and soluble fractions suggested the majority of acetylated proteins are either 
membrane-bound or membrane-associated (data not shown).   
 
Sirtuin 3 (SIRT3) is the primary NAD-dependent deacetylase in mitochondria [35].  We 
therefore carried out Western blot analyses to determine if hyper-acetylation is accompanied by 
a decrease in SIRT3 levels.  SIRT3 is produced as a 49 kDa protein and processed when it 
enters the mitochondria.  In mice, both a full length (49 kDa) and processed versions of SIRT3 
are found in the mitochondria [36].  It was found that the majority of SIRT3 detected in both the 
OVE26 and FVB heart mitochondria was in the form of the full-length enzyme (49 kDa). SIRT3 
content trended lower in OVE26 heart mitochondria (20% decrease, n=5), but failed to reach 
statistical significance (Fig 4C).   
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 Protein-lysine acetylation may promote metabolic inflexibility:  To evaluate the 
contribution of protein-lysine acetylation to metabolic inflexibility we used an in vitro approach.  
Specifically, we hyper-acetylated proteins of isolated FVB control mitochondria by treatment 
with acetic anhydride (Ac2O). Ac2O preferentially acetylates primary amines at neutral pH and is 
used to selectively acetylate protein lysines [37].  We observed that treatment of FVB heart 
control mitochondria with increasing amounts of acetic anhydride led to a concentration-
dependent increase in protein lysine acetylation, as measured by Western blot analysis (Figure 
5A).  Remarkably, treatment of FVB mitochondria with a low concentration of Ac2O (25 μM) 
induced the acetylation of proteins that were similar in profile to the banding pattern of OVE26 
heart mitochondria (Fig. 5B).  This may reflect that these recognized proteins are highly 
abundant, most susceptible to acetylation, or exceptionally recognized by the anti-acetyllysine 
antibody. 
 
 Having determined that 25 μM Ac2O acetylates in a manner similar to that of OVE26 
diabetic mice, we next examined the functional consequence of this treatment.  It was found that 
25 μM Ac2O preferentially inhibits glutamate- (30.1%) and pyruvate-supported (61.7%) 
respiration but had less of an effect on palmitoylcarnitine-supported respiration (16.1% 
decrease). The inhibitory effect of AC2O on oxidative phosphorylation is not surprising given the 
nonselective nature of this reagent and the high frequency of protein lysines.   However, the 
differential sensitivity to AC2O-mediated inhibition in the presence of varying substrates may 
reflect the unique susceptibility of protein lysines of different metabolic pathways to modification.   
 
 The effect of acetylation on mitochondrial free radical production:  Stimulation in 
mitochondria-derived free radical generation is implicated in the progression of diabetic 
cardiomyopathy.  We next examined whether the metabolic inflexibility observed in OVE26 
heart mitochondria was accompanied by an increase in free radical production.  For these 
experiments, FVB wild-type and OVE26 mitochondria were disrupted by freeze/thaw and the 
production of superoxide anion at maximal respiratory rate was directly assessed by measuring 
the NADH-driven, SOD-sensitive increase in 2-hydroxyethidium fluorescence.  This assay has 
an advantage over fluorescence based H2O2-detecting assays in intact mitochondria in that it is 
not dependent upon endogenous dismutation rates of superoxide.  In addition, H2O2 detection 
rates in intact mitochondria may under-represent ETC derived superoxide because it only 
determines H2O2 that escaped endogenous H2O2 scavenging pathways and diffused through 
both the inner and outer mitochondrial membranes.   Representative kinetic traces of 
superoxide production are shown in Fig. 6A and demonstrate measured superoxide rates are 
sensitive to addition of exogenous SOD1.  As shown in Figs. 6A and 6B, there is a significant 
increase in superoxide production in OVE26 heart mitochondria (23.5%) compared to FVB 
controls.  We next examined whether chemically induced metabolic inflexibility, using 25 μM 
Ac2O, was sufficient to increase mitochondrial superoxide production.  As shown in Fig. 6B, 
treatment of FVB control mitochondria with the acetylating agent induced a 27.2% increase in 
superoxide production.   
 
DISCUSSION 
 
 In the present report, we demonstrate that heart mitochondria from a chronic model of 
type 1 diabetes exhibit a significant decrease in maximal rates of respiration when using non-
fatty acid substrates.  Surprisingly, the maximal rate of respiration as well as respiratory control 
ratio were unchanged between FVB and OVE26 heart mitochondria when palmitoylcarnitine 
was used as a substrate.  This result demonstrates that mitochondria are not damaged to an 
extent that has affected mitochondrial integrity or capacity to perform maximal oxidative 
phosphorylation prior to the onset of diabetic cardiomyopathy.  A similar observation was made 
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to a lesser extent in Akita mice, another chronic model of type 1 diabetes [6]. However, in that 
study, it was concluded that the decrease in non-fatty acid supported respiration was likely 
attributable to a deficit in complex I activity.  However, as we report here we observed no 
decrease in NADH oxidase activity in 2-month old mice suggesting deficiencies in complex I 
activity are either not present or not to an extent that decreases overall electron transport chain 
activity.    
 
The mechanisms responsible for the observed inhibition in respiration with non-fatty acid 
substrates were shown to be multifaceted.  They include a decrease in PDH and complex II 
activities.  In the case of PDH this decrease in activity is attributable in part to hyper-
phosphorylation of the E1 subunit that is observed in OVE26 heart mitochondria relative to FVB.  
In addition there may be other contributing factors, such as increased acetyl-CoA production 
[33, 38], that contribute to feedback inhibition of PDH activity.  Finally, it is possible that other 
post-translation modifications, such as oxidation or lysine-acetylation, also contribute to 
decreased PDH activity. The mechanisms behind complex II inhibition are less clear.  However, 
complex II has been previously described as a target of oxidative modification in an STZ-
induced model of type 1 diabetes [39].  In addition, it has been shown that complex II is 
negatively regulated by protein acetylation [40].  The relative contribution of oxidation and 
acetylation to decreased complex II activity in the diabetic heart is the subject of future studies.   
 
Decreased respiration observed with succinate and pyruvate are largely explained by 
deficits in their respective enzymatic entry points into oxidative phosphorylation.   However, it is 
less clear what is inducing the decrease in respiration with glutamate as substrate.  We found 
no changes in glutamate/oxaloacetate transaminase activity.  We speculate that the observed 
hyper-acetylation may be contributing to a global change in mitochondrial metabolism that 
decreases anaplerotic reactions.  This hypothesis is supported by our finding that in FVB control 
heart mitochondria chemically induced acetylation preferentially inhibits respiration by non-fatty 
acid substrates, mimicking the OVE26 characteristics.     
 
Hyper-acetylation may be an important contributor to the increased oxidative stress 
associated with the progression of diabetes and diabetic cardiomyopathy.  For example, 
acetylation of SOD2 is a negative regulator of SOD2 activity [21].  Likewise, acetylation of 
isocitrate dehydrogenase 2 inhibits its activity [22], which may subsequently result in a decrease 
in the production of NADPH available for reduction of glutathione.  Such changes in antioxidant 
capacity may occur concomitantly with acetylation-mediated inhibition of electron transport 
chain components, such as complexes I and II.  Acetylation has been shown to inhibit their 
activities [18, 40], but its effects on subsequent increases in free radical production have not 
been determined.  
  
 The underlying cause of hyper-acetylation is not immediately apparent.  The level of 
SIRT3 was decreased in OVE26 heart mitochondria, but not to a statistically significant extent. 
Decreases in SIRT3 activity, as mediated by post-translational modifications, may also be 
contributory to increased acetylation.  For example, SIRT3 itself is a target of oxidative 
inactivation [41].  This may be significant given our findings of increased superoxide production 
in OVE26 heart mitochondria.  It is also possible that the increase in acetylation may be 
promoted by the metabolic conditions of OVE26 mice.  These mice exhibit high levels of 
circulating triglycerides [42], and as we demonstrate here, are metabolically inflexible at the 
mitochondrial level of substrate selection.  A constant use of fatty acids may be expected to 
increase acetyl-CoA content [38] and the ratio of NADH/NAD+.  Increased acetyl-CoA, the most 
likely carbon donor for protein lysine acetylation, would promote acetylation while the increased 
NADH/NAD+ ratio would impair the activity of SIRT3, which uses NAD+ as a cofactor.   
Biochemical Journal Immediate Publication. Published on 03 Oct 2012 as manuscript BJ20121038
TH
IS
 IS
 N
O
T 
TH
E 
VE
RS
IO
N 
O
F 
RE
CO
RD
 - 
se
e 
do
i:1
0.
10
42
/B
J2
01
21
03
8
Ac
ce
pte
d M
nu
cri
pt
Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
© 2012 The Authors Journal compilation © 2012 Biochemical Society
 9 
 
 As we demonstrate, changes in protein lysine acetylation are likely to have significant 
effects on mitochondrial function.  For example, nonspecific chemical acetylation of control 
mitochondria preferentially inhibits mitochondrial respiration by non-fatty acid substrates.  Future 
studies identifying these preferentially acetylated proteins may offer insights into the 
mechanisms whereby metabolic dysfunction leads to irreversible loss of mitochondrial function 
and the progression of diabetic cardiomyopathy.   
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TABLE 1. Comparison of MRI-derived LV systolic function and wall thickness between 
FVB control and OVE26 mice.  Results represent measurements from 5 experiments.   
 
  
 
Weight 
 
Ejection 
Fraction (%) 
 
Fractional 
Shortening 
(diameter, %) 
 
ES Wall 
Thickness  
(mm) 
 
ED Wall Thickness  
(mm) 
FVB 28.4 ± 1.9g   68.9 ± 15.0 40.7± 5.1 1.7 ± 0.1 0.9 ± 0.1 
OVE26 21.4 ± 1.7g* 83.1 ± 8.2 45.5 ± 7.6 1.5 ± 0.1 0.9 ± 0.1 
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FIGURE LEGENDS 
 
Figure 1.  OVE26 heart mitochondria have impaired mitochondrial respiration when using 
non-fatty acid substrates.  Mitochondrial respiration was measured, as described in 
Experimental, using either 10 mM glutamate and 2.5 mM malate, 0.1 mM pyruvate and 1.0 mM 
malate, 10 mM succinate, or 25 μM palmitoylcarnitine and 0.1 mM malate.  A. Representative 
oxygen traces with each of the used substrates.  B.  Average state 3 respirations from n ≥ 5 
experiments. Values represent means ± S.E. (n=5).  Symbols (*) indicate statistical significance 
(p < 0.05) between OVE26 and FVB controls as determined by Student’s t-test. 
 
Figure 2.  Pyruvate dehydrogenase activity is decreased in OVE26 heart mitochondria, 
and this corresponds to increased phosphorylation.  A.  PDH activity was measured by 
spectrophotometry as described in Experimental. Values represent means ± S.E (n=5). B.  
Western blot analysis of total PDH E1 and phospho-293 E1 in heart mitochondria (20 μg of total 
mitochondrial protein per well) of three representative FVB wild-type and OVE26 mice. The E2 
subunit of KGDH is shown as a loading control.  The ratio of phospho-293 E1 to total E1, as 
determined by densitometry, is shown.  Values represent means ± S.D (n=6). Symbols (*) 
indicate statistical significance (p < 0.05) between OVE26 and FVB controls as determined by 
Student’s t-test. 
  
Figure 3. Succinate dehydrogenase (SDH; complex II) activity is decreased in OVE26 
heart mitochondria.  Complex II activity was measured in different metabolic states.  
Mitochondria (0.25 mg/mL) were incubated in buffer B with 10 mM succinate for 2.0 min prior to 
the spectrophotometric measurement of complex II activity as described in Experimental. 
Values represent means ± S.E. (n=5).  Symbols (*) indicate statistical significance (p < 0.05) 
between OVE26 and FVB controls as determined by Student’s t-test.   
 
Figure 4.  Heart mitochondria from OVE26 mice exhibit hyper-acetylation but no 
significant decrease in SIRT3 content. A. Heart mitochondria from FVB wild-type or OVE26 
mice were analyzed by Western blot using a commercially available (Cell Signaling) anti-
acetylated lysine antibody. Comparison of two representative FVB wild-type and OVE26 mouse 
mitochondria are shown (left). Western blot of mitochondrial protein, SDHA, is shown as a 
loading control.  Densitometry of the entire lane was performed as described in Experimental 
(right). Values represent means ± S.E. (n=5).  Symbols (*) indicate statistical significance (p < 
0.02) between OVE26 and FVB controls as determined by Student’s t-test.  B. 10 μg of either 
mitochondrial or cytosolic proteins from OVE26 or FVB mice were analyzed by Western blot 
using an anti-acetylated lysine antibody.  The blot development was overexposed to 
demonstrate the large difference in protein lysine acetylation between cytosolic and 
mitochondrial proteins (left).  An SDS-PAGE gel with 20 μg of each sample per lane, and 
stained as described in Experimental, is shown on the right.  C. Western blot analysis of SIRT3 
in three representative mitochondrial samples from OVE26 and FVB heart mitochondria are 
demonstrated. Western blot analysis against SDHA was performed as a loading control.  The 
content of SIRT3 in FVB and OVE26 heart mitochondria was determined by densitometry as 
described in Experimental.  Values represent means ± S.E. (n=5).  There was a trend of 
decreased SIRT3 in OVE26 heart mitochondria that failed to reach statistical significance by a 
Student’s t-test (p=0.11).     
 
Figure 5.  The acetylation profile and respiratory activities of control mitochondria 
treated with acetic anhydride is similar to OVE26.  A. FVB wild type heart mitochondria (0.25 
mg/mL) were treated with indicated amounts of Ac2O for 2.0 min at 20 °C, and the reaction then 
stopped with the addition of 3.0 mM lysine.  Samples were then analyzed by Western blot 
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analysis using an anti-acetylated lysine antibody.  B. Control FVB heart mitochondria were 
treated with 25 μM Ac2O and analyzed by Western blot, as in panel A.  Acetylation is shown 
before and after treatment with Ac2O and compared to two unique OVE26 heart mitochondria 
samples.  C. The effect of Ac2O on state 3 respiration supported by three different oxidizable 
sources, measured as in Fig. 1, is compared to FVB control and OVE26 heart mitochondria. 
Values represent means ± S.E. (n≥4).  Symbols (*) indicate statistical significance (p < 0.05) 
between samples and FVB controls as determined by Student’s t-test.   
 
Figure 6.  OVE26 heart mitochondria and FVB mitochondria acetylated with Ac2O 
produce more superoxide than FVB controls. A. Superoxide production was measured 
fluorometrically as the SOD-sensitive rate at which disrupted mitochondria oxidize hydroethidine 
in the presence of NADH. Displayed are representative 2-hydroxyethidium formation traces for 
FVB and OVE26 heart mitochondria in the absence or presence of CuZn-SOD (8.0 U/mL).  B. 
FVB control heart mitochondria were incubated in the presence of 25 μM Ac2O for 2.0 min, as 
indicated, and then the reaction stopped by the addition of 3.0 mM lysine. SOD-sensitive rates 
are compared to FVB control and OVE26 values.  Values represent means ± S.E. (n=5).  
Symbols (*) indicate statistical significance (p < 0.05) between samples as determined by 
Student’s t-test.   
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Figure 1. 
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